Fibrinolysis markers as predictive indicators of neoadjuvant chemotherapy efficacy in ovarian cancer patients
D-dimer, FIB, and FDP are elevated in OC patients and demonstrate a potential role as noninvasive markers for assessing NACT efficacy, offering valuable insights for treatment planning.
Authors
- N Li (ORCID: https://orcid.org/0000-0001-9933-8674)
- Xuexue Yin
- Xiaolin Zhu (ORCID: https://orcid.org/0009-0007-7628-3624)
- Xueqin Sun (ORCID: https://orcid.org/0000-0001-5292-3112)
Institutions
- Central Hospital of Zibo (CN)
Publication Details
- Journal
- Future Oncology
- Published
- 2025-09-29
- DOI
- https://doi.org/10.1080/14796694.2025.2564058
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00